Your browser doesn't support javascript.
loading
Tacrolimus therapy in primary Sjögren's syndrome with refractory immune thrombocytopenia: a retrospective study.
Xu, Rong; Yan, Qing; Gong, Yan; Cai, Cheng-Sen; Wu, Jian; Yuan, Xin-Yu; Long, Xian-Ming.
Afiliação
  • Xu R; Department of Rheumatology and Immunology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu province, China.
  • Yan Q; Department of Rheumatology and Immunology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian province, China.
  • Gong Y; Department of Rehabilitation Medicine, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu province, China.
  • Cai CS; Department of Haematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu province, China.
  • Wu J; Department of Rheumatology and Immunology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu province, China.
  • Yuan XY; Department of Respiratory and Critical Care Medicine, Du Shu Lake Hospital Affiliated to Soochow University, Suzhou, Jiangsu province, China. 1064332454@qq.com.
  • Long XM; Department of Rheumatology and Immunology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu province, China. xmlong@suda.edu.cn.
Clin Exp Rheumatol ; 40(12): 2268-2274, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36135951

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren / Púrpura Trombocitopênica Idiopática Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren / Púrpura Trombocitopênica Idiopática Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China